BAM
ITCI

Belpointe Asset Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Belpointe Asset Management’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,256
Closed -$68K – 3516
2023
Q1 		$68K Buy
1,256
+42
+3% +$2.27K ﹤0.01% 1536
2022
Q4 		$64.2K Buy
+1,214
New +$64.2K ﹤0.01% 1471